PMID: 698554Aug 19, 1978Paper

Treatment of Raynaud's phenomenon by fibrinolytic enhancement

British Medical Journal
P E JarrettN L Browse

Abstract

Twenty patients with advanced Raynaud's phenomenon, in 14 of whom it was secondary to scleroderma, were treated with stanozolol, an anabolic steroid that enhances natural fibrinolysis. All showed an increase in hand blood flow and a reduction in symptoms during treatment. This response may have been caused by the lysis of fibrin deposited in the digital arteries and the reduction of plasma viscosity. Stanozolol is a useful addition to the treatment of patients with advanced Raynaud's phenomenon who have trophic changes.

References

Feb 19, 1977·British Medical Journal·N L BrowseM Morland
Oct 1, 1952·Archives of Biochemistry and Biophysics·T ASTRUP, S MULLERTZ
May 22, 1965·Lancet·R PRINGLEJ P WEAVER

❮ Previous
Next ❯

Citations

Jan 1, 1990·Cardiovascular Drugs and Therapy·J D Coffman
Jul 1, 1997·Thrombosis Research·D A Handley, T E Hughes
Aug 6, 1983·Lancet·K LaffertyL T Cotton
May 14, 1983·Lancet·J DebonoP Betts
Feb 28, 2004·Journal of the American Academy of Dermatology·Alexander L Berlin, Kevin Pehr
Nov 1, 1990·International Journal of Dermatology·M Matucci-CerinicM Caignoni
Aug 1, 1981·Annals of the Rheumatic Diseases·M F MartinJ D Kirby
Jul 1, 1990·Annals of the Rheumatic Diseases·A LeakP Woo
Jan 1, 1991·Annals of the Rheumatic Diseases·M I JaysonL Taylor
Oct 21, 1978·British Medical Journal·A C Newland, M J Wood
Oct 18, 1980·British Medical Journal·P C CliffordP A Dieppe
Jun 23, 1984·British Medical Journal·M I Jayson
Mar 3, 1990·BMJ : British Medical Journal·E D Cooke, A N Nicolaides
Feb 1, 1984·Journal of Clinical Pathology·R A HuttonP Dandona
Aug 1, 1984·Journal of Clinical Pathology·G S LucasJ Stuart
Jan 1, 1995·International Reviews of Immunology·M B Kahaleh
Jan 1, 1980·The British Journal of Dermatology·K H Nilsen
Jul 1, 1982·Clinical and Experimental Dermatology·J M Edwards
Oct 15, 1986·Thrombosis Research·M SmallC D Forbes
Oct 1, 1982·Thrombosis Research·M SmallC R Prentice
May 1, 1994·Journal of the American Academy of Dermatology·T LottiM Matucci-Cerinic
Aug 1, 1992·The Journal of Hand Surgery : Journal of the British Society for Surgery of the Hand·B M O'BrienT V Oliver
Jan 1, 1981·The British Journal of Surgery·M L AyresN L Browse
Oct 1, 1979·The British Journal of Surgery·M J O'ReillyL T Cotton
Jun 1, 1982·The British Journal of Surgery·M HoareA Nicolaides
Nov 1, 1990·International Journal of Dermatology·I GhersetichT Lotti
Aug 1, 1981·Australian Journal of Ophthalmology·I FavillaL Kowal
Jan 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·J G LarkinB M Frier
Mar 30, 2000·Autoimmunity·M B Kahaleh, E C LeRoy
Jan 1, 1981·Acta Medica Scandinavica·B NilssonU Hedner
Oct 1, 1993·Scottish Medical Journal·D J Veale, J J Belch
Jul 1, 1981·The British Journal of Surgery·E Ernst
Jan 1, 1984·Acta Medica Scandinavica·H NilssonI Ringqvist

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.